Zidovudine


CAS No. : 30516-87-1

(Synonyms: Azidothymidine; AZT; ZDV)

30516-87-1
Price and Availability of CAS No. : 30516-87-1
Size Price Stock
500mg $9 In-stock
1g $17 In-stock
5g $26 In-stock
25g $129 In-stock
100g $454 In-stock
200 g Get quote
500 g Get quote
We match the lowest price on market.

We offer a substantial discount on larger orders, please inquire via [email protected]

or Fax: (86)21-58955996

Inquiry for price and availability only. Please place your order via our email or fax.

Cat. No. : HY-17413
M.Wt: 267.24
Formula: C10H13N5O4
Purity: >98 %
Solubility: DMSO : ≥ 100 mg/mL;H2O : 16.67 mg/mL (ultrasonic;warming;heat to 60°C)
Introduction of 30516-87-1 :

Zidovudine is a nucleoside reverse transcriptase inhibitor (NRTI), widely used to treat HIV infection. IC50 & Target:NRTI, HIV[1]
CRISPR/Cas9[2] In Vitro:Zidovudine inhibits SVG, Primary human fetal astrocytes (PFA), peripheral blood mononuclear cells (PBMC), and monocyte-derived macrophages (MDM) with EC50 of 17, 1311, 8, and 5 nM, respectively. Zidovudine inhibits SVG, PFA, PBMC, and MDM with EC90 of 0.205 μM, 44.157 μM, 0.481 μM, and 0.219 μM, respectively[1]. The Cas9-mediated ablation of CXCR4 demonstrated high specificity and negligible off-target effects without affecting cell division and propagation[2]. In Vivo:Intravitrous injection of the NRTIs Lamivudine (3TC), Zidovudine (AZT), or Abacavir (ABC) suppresses the laser-induced choroidal neovascularization (CNV) in wild-type mice compared to PBS vehicle. The mean level of VEGF-A in the RPE/choroid, which peaks on day 3 after laser injury, is significantly reduced in 3TC-, AZT- and ABC-treated eyes compared with control eyes in wild-type mice, but not inP2rx7-/- mice[3].

Your information is safe with us.